{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:01Z","timestamp":1789387441015,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"King Gustaf Vth 80-year Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["K2014-52X-14045-14"],"award-info":[{"award-number":["K2014-52X-14045-14"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/rheumatology\/key222","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T01:21:05Z","timestamp":1530840065000},"page":"2149-2157","source":"Crossref","is-referenced-by-count":21,"title":["Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment"],"prefix":"10.1093","volume":"57","author":[{"given":"Sevim Barbasso","family":"Helmers","sequence":"first","affiliation":[{"name":"Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden"},{"name":"Unit of Rheumatology, Karolinska University Hospital, Solna, Sweden"},{"name":"Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Bruton","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden"},{"name":"Unit of Rheumatology, Karolinska University Hospital, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingela","family":"Loell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden"},{"name":"Unit of Rheumatology, Karolinska University Hospital, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kristin","family":"Ulfgren","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden"},{"name":"Unit of Rheumatology, Karolinska University Hospital, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J","family":"Gracie","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B","family":"McInnes","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden"},{"name":"Unit of Rheumatology, Karolinska University Hospital, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"key\n\t\t\t\t2018112705033004400_key222-B1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.70.5.569","article-title":"Progress in inflammatory myopathies: good but not good enough","volume":"70","author":"Dalakas","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.berh.2016.04.007","article-title":"Idiopathic inflammatory myositis","volume":"30","author":"Tieu","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11926-009-0041-1","article-title":"The inflammatory milieu in idiopathic inflammatory myositis","volume":"11","author":"Reed","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B8","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1517\/14728222.11.11.1369","article-title":"Tumor necrosis factor as a therapeutic target of rheumatologic disease","volume":"11","author":"Ackermann","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2174\/1389201019666171226151852","article-title":"Biologics in inflammatory and immunomediated arthritis","volume":"18","author":"Luchetti","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","article-title":"Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/annrheumdis-2012-202857","article-title":"Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up","volume":"73","author":"Zong","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/meth.1999.0837","article-title":"Interleukin-18","volume":"19","author":"Dinarello","year":"1999","journal-title":"Methods"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/eji.200535402","article-title":"Expression and alternative processing of IL-18 in human neutrophils","volume":"36","author":"Robertson","year":"2006","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2249.2004.02475.x","article-title":"Interleukin-18 as a potential target in inflammatory arthritis","volume":"136","author":"Gracie","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/ar1497","article-title":"Interleukin-18: a therapeutic target in rheumatoid arthritis?","volume":"7","author":"McInnes","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/IAI.57.2.590-595.1989","article-title":"Endotoxin-induced serum factor that stimulates gamma interferon production","volume":"57","author":"Nakamura","year":"1989","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2249.1994.tb06032.x","article-title":"MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies","volume":"95","author":"Bartoccioni","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B23","first-page":"467","article-title":"Leucocyte\/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM)","volume":"104","author":"Cid","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18","volume":"73","author":"Gracie","year":"2003","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","article-title":"Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis","volume":"43","author":"Lundberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","article-title":"Expression of cell adhesion molecules in inflammatory myopathies","volume":"59","author":"Tews","year":"1995","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B28","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B29","first-page":"940","article-title":"Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis","volume":"27","author":"Nyberg","year":"2000","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B30","doi-asserted-by":"crossref","first-page":"R447","DOI":"10.1186\/ar1209","article-title":"Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren\u2019s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/14712598.7.1.31","article-title":"Interleukin-18 as a potential therapeutic target in chronic autoimmune\/inflammatory conditions","volume":"7","author":"Bombardieri","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B33","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","article-title":"Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies","volume":"146","author":"Tucci","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1196\/annals.1381.020","article-title":"Increased IL-18 production by dendritic cells in active inflammatory myopathies","volume":"1107","author":"Tucci","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B36","first-page":"1380","article-title":"A functional index in myositis","volume":"23","author":"Josefson","year":"1996","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI7317","article-title":"A proinflammatory role for IL-18 in rheumatoid arthritis","volume":"104","author":"Gracie","year":"1999","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/ard.2005.051086","article-title":"Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis","volume":"65","author":"Dorph","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B39","first-page":"19","article-title":"Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production","volume":"10","author":"Mosaad","year":"2003","journal-title":"Egypt J Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family","volume":"103","author":"Dinarello","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2011-200495","article-title":"Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor alpha expression in muscle tissue of patients with polymyositis or dermatomyositis","volume":"71","author":"Zong","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13075-016-0974-5","article-title":"Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis","volume":"18","author":"Pandya","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B43","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/rheumatology\/kew288","article-title":"Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis","volume":"55","author":"Ekholm","year":"2016","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B44","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"Response to: \u20182017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?\u2019 by Malaviya","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112705033004400_key222-B45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/12\/2149\/26769450\/key222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T05:25:58Z","timestamp":1604553958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/12\/2149\/5068359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,8]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key222","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,8]]}}}